Page last updated: 2024-11-05

zonisamide and Cholera Infantum

zonisamide has been researched along with Cholera Infantum in 2 studies

Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.

Research Excerpts

ExcerptRelevanceReference
"Zonisamide safety was evaluated based on a postmarketing surveillance study of patients treated for 1-3 years."1.34Erratum to "Safety of zonisamide therapy: prospective follow-up survey.". ( Ohtahara, S; Yamatogi, Y, 2007)
"Zonisamide safety was evaluated based on a postmarketing surveillance study of patients treated for 1-3 years."1.32Safety of zonisamide therapy: prospective follow-up survey. ( Ohtahara, S; Yamatogi, Y, 2004)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ohtahara, S2
Yamatogi, Y2

Other Studies

2 other studies available for zonisamide and Cholera Infantum

ArticleYear
Safety of zonisamide therapy: prospective follow-up survey.
    Seizure, 2004, Volume: 13 Suppl 1

    Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Age Factors; Aged; Anticonvulsants; Child; Child, Pr

2004
Erratum to "Safety of zonisamide therapy: prospective follow-up survey.".
    Seizure, 2007, Volume: 16, Issue:1

    Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Age Factors; Aged; Anticonvulsants; Child; Child, Pr

2007